[HTML][HTML] Antidepressant mechanism of ketamine: perspective from preclinical studies
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
[PDF][PDF] Antidepressant mechanism of ketamine: perspective from preclinical studies
L Scheuing, CT Chiu, HM Liao… - Front. Neurosci. 9: 249 …, 2015 - scienceopen.com
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
[PDF][PDF] Antidepressant mechanism of ketamine: perspective from preclinical studies
L Scheuing, CT Chiu, HM Liao… - Front. Neurosci. 9: 249. doi …, 2015 - core.ac.uk
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
Antidepressant mechanism of ketamine: perspective from preclinical studies.
L Scheuing, CT Chiu, HM Liao… - Frontiers in …, 2015 - europepmc.org
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
Antidepressant mechanism of ketamine: perspective from preclinical studies
L Scheuing, CT Chiu, HM Liao… - Frontiers in …, 2015 - pubmed.ncbi.nlm.nih.gov
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
[HTML][HTML] Antidepressant mechanism of ketamine: perspective from preclinical studies
L Scheuing, CT Chiu, HM Liao… - Frontiers in …, 2015 - ncbi.nlm.nih.gov
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
Antidepressant mechanism of ketamine: perspective from preclinical studies.
L Scheuing, CT Chiu, HM Liao… - Frontiers in …, 2015 - search.ebscohost.com
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …
Antidepressant mechanism of ketamine: perspective from preclinical studies.
L Scheuing, CT Chiu, HM Liao… - Frontiers in …, 2015 - europepmc.org
A debilitating mental disorder, major depressive disorder is a leading cause of global
disease burden. Existing antidepressant drugs are not adequate for the majority of …
disease burden. Existing antidepressant drugs are not adequate for the majority of …